Zionsville, IN, United States of America

Christina Martinez Brokaw

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eli Lilly and Company. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christina Martinez Brokaw. Retrieved from https://idiyas.com/inventor/christina-martinez-brokaw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christina Martinez Brokaw: Innovator in cGAS Inhibitors

Introduction

Christina Martinez Brokaw is a prominent inventor based in Zionsville, IN (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of cGAS inhibitors. Her work focuses on novel compounds that have the potential to treat immune-mediated diseases.

Latest Patents

Christina holds 1 patent related to cGAS inhibitors. The present invention pertains to novel cGAS inhibitor compounds, which are designed to be used in pharmaceutical compositions. These compounds are aimed at treating various pathological conditions, including immune-mediated diseases.

Career Highlights

Christina is currently employed at Eli Lilly and Company, where she continues to advance her research and development efforts. Her role at the company allows her to collaborate with other experts in the field and contribute to innovative solutions in healthcare.

Collaborations

Some of Christina's notable coworkers include Francisco Javier Agejas Chicharro and Adel Ahmed. Their collaborative efforts enhance the research environment and foster innovation within the company.

Conclusion

Christina Martinez Brokaw is a dedicated inventor whose work on cGAS inhibitors holds promise for treating immune-mediated diseases. Her contributions to the pharmaceutical industry exemplify the impact of innovative research on healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…